Glenmede Trust Company »

Catalyst Pharmaceutical Partners shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 100k 15.94
2023-09-30 $566k 48k 11.69
2023-06-30 $469k 28k 16.58
2023-03-31 $469k 28k 16.58
2022-09-30 $217k 17k 12.67
2022-06-30 $121k 18k 6.92
2022-03-31 $180k 22k 8.08
2021-12-31 $146k 22k 6.54
2021-09-30 $112k 22k 5.00
2020-09-30 $7.0k 2.4k 2.90
2020-06-30 $3.0k 835 3.59